SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Clarke who wrote (163)8/21/1998 11:20:00 AM
From: Dynamicist  Read Replies (2) of 196
 
Thanks Kevin. DID THIS COMPANY REALLY CURE HIV/AIDS?

August 19, 1998 10:32 PM

LAYTON, Utah, Aug. 20 /PRNewswire/ -- Medical Discoveries, Inc. MLSC announced today that its pharmaceutical drug, MDI-P, has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in killing HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).

These tests were conducted at a major National Institute of Health approved HIV research laboratory. It is the Company's intention to publish these data upon the completion of ongoing studies. These data confirm and validate nearly seven years of ongoing research and development on the ability of MDI-P to target the HIV virus.

"The importance of MDI-P is highlighted by the fact that it works on mechanisms which are different than those targeted by the currently approved anti-retroviral agents," stated MDI VP and Chief Technical Officer, William J. Novick, Ph.D.

Experiments are ongoing to maximize the drug's efficacy. Medical Discoveries, Inc., intends to submit an Investigational New Drug application with the Food and Drug Administration upon the completion of certain additional testing currently in progress.

Medical Discoveries, Inc. is a bio-pharmaceutical corporation focused on the research, development and commercialization of electrolysis based technologies targeted at anti-viral (HIV/AIDS), anti-bacterial, anti-fungal and other applications.

SOURCE Medical Discoveries, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext